Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount Award Date, One Award Date, One [Member] Award Date, One Financial Instrument [Axis] Financial Instrument [Axis] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Common stock, $0.0001 par value; 300,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 72,327,320 and 60,575,369 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Repurchase of common shares to pay employee withholding taxes Payment, Tax Withholding, Share-Based Payment Arrangement Schedule of Outstanding Debt and Interest Expense Schedule of Long-Term Debt Instruments [Table Text Block] Other, noncurrent Other Assets, Miscellaneous, Noncurrent Embedded derivatives liability Fair value of bifurcated embedded derivatives Embedded Derivative, Fair Value of Embedded Derivative Liability Maximum number of patients per arm in trial Maximum Number Of Patients Per Arm In Trial Maximum Number Of Patients Per Arm In Trial Entity Ex Transition Period Entity Ex Transition Period Restatement Determination Date Restatement Determination Date Compensation and other employee liabilities Employee-related Liabilities Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Derivative Instrument [Axis] Derivative Instrument [Axis] Warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Payment obligation, term Collaborative Arrangement, Term Collaborative Arrangement, Term Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Amendment Flag Amendment Flag Current liabilities Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Marketable Securities [Line Items] Marketable Securities [Line Items] Schedule of Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] License Agreements Lonza License Agreement [Member] Lonza License Agreement Minimum required payment Debt Instrument, Minimum Required Payment Debt Instrument, Minimum Required Payment Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Assets included in: Assets, Fair Value Disclosure [Abstract] Cash and cash equivalents Cash and Cash Equivalents [Abstract] Unvested beginning balance (in shares) Unvested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Weighted-average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Tranche one Share-Based Payment Arrangement, Tranche One [Member] Amortization of premiums and accretion of discounts on marketable securities, net Accretion (Amortization) of Discounts and Premiums, Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax [Abstract] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Entity Address, City or Town Entity Address, City or Town Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Common stock and preferred stock, shares authorized (in shares) Common Stock and Preferred Stock, Shares Authorized Common Stock and Preferred Stock, Shares Authorized Sales and Royalties Sales And Royalties [Member] Sales And Royalties Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Other income (expense) Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Principle borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share of Common Stock Earnings Per Share, Policy [Policy Text Block] Schedule of Financial Information about Company's Operating Segment Segment Reporting [Table Text Block] 2024 Registration Statement 2024 Registration Statement [Member] 2024 Registration Statement [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] James Doherty, Plan 2, Shares Of Common Stock [Member] James Doherty, Plan 2, Shares Of Common Stock Schedule of the Fair Value using Level 3 Significant Unobservable Inputs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Debt, long-term Total debt, long-term Long-Term Debt Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding STOCKHOLDERS’ EQUITY Equity [Text Block] Security Exchange Name Security Exchange Name James Doherty Plan 1 [Member] James Doherty Plan 1 Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Russell Barton Plan 1 [Member] Russell Barton Plan 1 Royalty percentage Collaborative Arrangement, Royalty Percentage Collaborative Arrangement, Royalty Percentage Purchases of marketable securities Payments to Acquire Marketable Securities Total fair value Liabilities, Fair Value Disclosure Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Change in fair value of embedded derivatives Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Segment Information Segment Reporting, Policy [Policy Text Block] Marketable Securities [Table] Marketable Securities [Table] Name Outstanding Recovery, Individual Name Proceeds from maturities and sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Aggregate Intrinsic Value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Intrinsic Value Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Award Date [Axis] Award Date [Axis] Unrealized (loss) gain on marketable securities Unrealized (loss) gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Principal value of Term Loan, including Final Payment of $1,635 Total principal payments due for Term Loan Long-Term Debt, Gross Term Loan, First Tranche Term Loan, First Tranche [Member] Term Loan, First Tranche Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Shares issuable upon exercise of warrant Common Stock Warrant Warrant [Member] Weighted-average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Award Date [Domain] Award Date [Domain] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Debt, short-term Less: debt, short-term Short-Term Debt Noncash interest expense Other Noncash Expense, Interest Other Noncash Expense, Interest Shares of common stock outstanding maximum (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares of Common Stock Outstanding Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Shares of Common Stock Outstanding Maximum Other receivables Other Receivables Cash and Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Term Loan Term Loan [Member] Term Loan Award Timing Predetermined Award Timing Predetermined [Flag] Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Other Other Assets, Miscellaneous Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Fair Value Debt Securities, Available-for-Sale [Abstract] Covenant, proceeds from issuance of debt required Debt Instrument, Covenant, Proceeds From Issuance Of Debt Required Debt Instrument, Covenant, Proceeds From Issuance Of Debt Required Unvested beginning balance (in dollars per share) Unvested ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Realized gain on marketable securities Marketable Security, Realized Gain (Loss) Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Embedded Derivative Financial Instruments Embedded Derivative Financial Instruments [Member] Depreciation Depreciation Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Right-of-use asset Operating Lease, Right-of-Use Asset SUPPLEMENTAL FINANCIAL INFORMATION Supplemental Financial Information [Text Block] Supplemental financial information [Text block]. Greater than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer [Abstract] Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] SEGMENT REPORTING Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Net change in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Marketable securities Investments, Fair Value Disclosure Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] JCR Pharmaceuticals JCR Pharmaceuticals [Member] JCR Pharmaceuticals Eric Siemers [Member] Eric Siemers Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Total Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Money market securities Cash and Cash Equivalents, Fair Value Disclosure Outstanding balance (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Gross proceeds from issued shares of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Maximum threshold common stock issuable on exercise of incentive stock options (in shares) Share-Based Payment Arrangement, Maximum Threshold Common Stock Issuable on Exercise of Incentive Stock Options Share-Based Payment Arrangement, Maximum Threshold Common Stock Issuable on Exercise of Incentive Stock Options Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Vested and exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] DEBT Debt Disclosure [Text Block] Interest Interest Payable Repayments of debt Repayments of long-term debt Repayments of Long-Term Debt Discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Direct fees Debt Issuance Costs, Net Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Amortized Cost, Current Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Secured Debt Secured Debt [Member] Change in fair value of embedded derivatives Change in fair value of embedded derivatives Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Adoption Date Trading Arrangement Adoption Date Counterparty Name [Domain] Counterparty Name [Domain] Interest rate (as percent) Debt Instrument, Interest Rate, Stated Percentage Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Total other income Other income, net Nonoperating Income (Expense) Prepaid insurance Prepaid Insurance ASSETS Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Russell Barton [Member] Russell Barton Final payment fee Debt Instrument, Fee Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Operating lease liability Operating Lease, Liability Stock issuance offering costs Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Stock options outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax, Current Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax, Current Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Minimum required payment, outstanding debt requirement Debt Instrument, Minimum Required Payment, Outstanding Debt Requirement Debt Instrument, Minimum Required Payment, Outstanding Debt Requirement Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Private Placement Private Placement [Member] Outstanding stock maximum (as percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segment Number of Operating Segments Unvested RSUs RSUs Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Accumulated depreciation, property and equipment Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Proceeds from private placement, net of offering costs Proceeds from Issuance of Private Placement Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Remainder of 2026 Long-Term Debt, Maturity, Remainder of Fiscal Year Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity Equity, Attributable to Parent [Abstract] Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses Operating expenses Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Assumptions Used for Valuation of Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Variable interest rate (as percent) Debt Instrument, Basis Spread on Variable Rate City Area Code City Area Code Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Shares issuable upon conversion election for term loan facility Convertible Debt Securities [Member] Amortization of right-of-use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Name Forgone Recovery, Individual Name Weighted average period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Research and development service agreements Research And Development Service Agreements Research And Development Service Agreements Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Supplemental Financial Information [Abstract] Supplemental Financial Information [Abstract] Supplemental financial information [Abstract]. Statement [Line Items] Statement [Line Items] Research and development Research and Development Expense [Abstract] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock, shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance 2021 Equity Incentive Plan 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan Weighted average grant date fair value of options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Interest expense Interest Expense, Nonoperating Schedule of Share-Based Compensation Expense Related to Stock Options Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Other long-term assets Increase (Decrease) in Other Operating Assets DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Nature of Operations [Text Block] Issuance of common stock in connection with the private placement, net of offering costs (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Total Debt, Long-Term and Short-Term, Combined Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Other comprehensive gain (loss) Statement of Other Comprehensive Income [Abstract] Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total stock-based compensation Share-Based Payment Arrangement, Expense Marketable securities Marketable Securities, Current Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Stock options exercised for cash (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Cash equivalents Cash Equivalents, at Carrying Value 2013 Equity Incentive Plan 2013 Equity Incentive Plan [Member] 2013 Equity Incentive Plan Accumulated Deficit Retained Earnings [Member] Total operating expenses Operating Expenses Money market securities Money Market Funds [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Corporate debt securities Corporate Debt Securities [Member] Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Net cash provided by (used in) financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Liabilities included in: Liabilities, Fair Value Disclosure [Abstract] Russell Barton Plan 2 [Member] Russell Barton Plan 2 Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Research and development Research and Development Expense Award Date, Two Award Date, Two [Member] Award Date, Two Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Reportable Segment Reportable Segment [Member] Reportable Segment Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Financial Instruments [Domain] Financial Instruments [Domain] Common stock, number of voting rights Common Stock, Number Of Voting Rights Common Stock, Number Of Voting Rights Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Stock options exercised for cash Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] James Doherty, Plan 2, Shares Of Common Stock Received Upon Exercise Of Option Awards [Member] James Doherty, Plan 2, Shares Of Common Stock Received Upon Exercise Of Option Awards Underlying Securities Award Underlying Securities Amount Issuance of common stock in connection with the private placement, net of offering costs Stock Issued During Period, Value, New Issues Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Award Date, Three Award Date, Three [Member] Award Date, Three Research and development Research And Development Liability Research And Development Liability MARKETABLE SECURITIES Financial Instruments Disclosure [Text Block] Internally managed costs Research And Development, Internally-Managed Costs Research And Development, Internally-Managed Costs At The Market Offering At The Market Offering [Member] At The Market Offering Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Segment Reporting [Table] Segment Reporting [Table] Shares available for future grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Research and development service agreements, noncurrent Research And Development Service Agreements, Noncurrent Research And Development Service Agreements, Noncurrent Schedule of Aggregate Principal Payments Schedule of Maturities of Long-Term Debt [Table Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Weighted Average Remaining Contractual Life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Less than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months [Abstract] Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Current Fiscal Year End Date Current Fiscal Year End Date Warrant, fair value Warrants and Rights Outstanding Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Accretion of debt discount Amortization of Debt Discount (Premium) Schedule of Accrued Expenses and Other Current Liabilities Disclosure Of Accrued Expenses And Other Current Liabilities [Table Text Block] Disclosure of accrued expenses and other current liabilities [Table text block]. Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Current Equity Components [Axis] Equity Components [Axis] Product and Service [Domain] Product and Service [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Cash paid for income taxes Income Tax Paid, after Refund Received External costs Research And Development, External Costs Research And Development, External Costs Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Conversion, if-converted amount Debt Instrument, Convertible, If-converted Value Debt Instrument, Convertible, If-converted Value Unamortized debt discount Debt Instrument, Unamortized Discount Termination Date Trading Arrangement Termination Date Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Issuance of common stock for restricted stock units, net of shares withheld for taxes Restricted Stock, Value, Shares Issued Net of Tax Withholdings MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other assets, long-term Other assets, long-term Other Assets, Noncurrent Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued expenses and other current liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Schedule of Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Other, current Other Assets, Miscellaneous, Current Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Payment of upfront fees Collaborative Arrangement, Payment Of Upfront Fees Collaborative Arrangement, Payment Of Upfront Fees Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Warrant term Warrants and Rights Outstanding, Term Commitments and contingencies (Note 10) Commitments and Contingencies Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Debt securities, available-for-sale, allowance for credit losses Debt Securities, Available-for-Sale, Allowance for Credit Loss, Not Previously Recorded Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name [Axis] Counterparty Name [Axis] Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Other Commitments [Table] Other Commitments [Table] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Marketable securities Marketable Securities [Abstract] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Government and agency - U.S. Government and agency - U.S. US Government Agencies Debt Securities [Member] Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term James Doherty [Member] James Doherty PEO Name PEO Name Total Accrued Liabilities and Other Liabilities Restricted cash Restricted Cash Cash and cash equivalents and marketable securities Cash, Cash Equivalents, and Short-Term Investments Other segment expenses Segment Reporting, Other Segment Item, Amount Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Total interest expense related to debt Interest Expense, Debt Total Prepaid Expense and Other Assets Other Commitments [Line Items] Other Commitments [Line Items] Issuance of common stock for restricted stock units, net of shares withheld for taxes (in shares) Common stock issued in settlement of vested RSUs (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents and restricted cash at the beginning of the period Cash and cash equivalents and restricted cash at the end of the period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Accrued clinical trial expenses Accrued Clinical Trial Expenses, Current Accrued Clinical Trial Expenses, Current Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Employee Stock Employee Stock [Member] 2027 Long-Term Debt, Maturity, Year One Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Other Other Sundry Liabilities Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Restricted cash Restricted Cash, Noncurrent Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Cover [Abstract] Cover [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Interest expense based on the coupon interest rate of the outstanding debt Interest Expense, Debt, Excluding Amortization Derivative Contract [Domain] Derivative Contract [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Debt securities, available-for-sale, realized gains Debt Securities, Available-for-Sale, Realized Gain (Loss) Total liabilities and stockholders’ equity Liabilities and Equity Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax [Abstract] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax James Doherty Plan 2 [Member] James Doherty Plan 2 Shares issuable upon exercise of stock options Stock Options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Tabular List, Table Tabular List [Table Text Block] Development Development [Member] Development Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital Other expense, net Other Nonoperating Income (Expense) Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Ending balance, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative General and Administrative Expense Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Debt, long-term Debt Instrument, Fair Value Disclosure [Abstract] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Sale of stock, maximum authorized amount Sale of Stock, Maximum Authorized Amount Sale of Stock, Maximum Authorized Amount Sale of stock, commission rate to sales agents Sale of Stock, Commission Rate to Sales Agents Sale of Stock, Commission Rate to Sales Agents Adjustment to Compensation: Adjustment to Compensation [Axis] Cliff period Share-Based Compensation Arrangement by Share-Based Payment Award, Cliff Period Share-Based Compensation Arrangement by Share-Based Payment Award, Cliff Period Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Purchases of property and equipment Payments to Acquire Productive Assets Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total fair value Assets, Fair Value Disclosure Name Measure Name Registration Statement Registration Statement [Member] Registration Statement Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Dues and subscriptions Dues And Subscriptions Dues And Subscriptions Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position Future milestone payment received Collaborative Arrangement, Future Milestone Payment Collaborative Arrangement, Future Milestone Payment Term Loan, Second Tranche Term Loan, Second Tranche [Member] Term Loan, Second Tranche Name Trading Arrangement, Individual Name Non option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Effective interest rate (as percent) Debt Instrument, Interest Rate During Period Number of patients enrolled in trail Number Of Patients Enrolled In Trial Number Of Patients Enrolled In Trial Company Selected Measure Amount Company Selected Measure Amount Entity Address, Address Line Two Entity Address, Address Line Two Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Current assets Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule of Cash, Cash Equivalents and Restricted Cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] Schedule of Cash, Cash Equivalents and Restricted Cash Award Timing Method Award Timing Method [Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Accrued clinical trial expenses Increase (Decrease) in Accrued Clinical Trial Expenses Increase (Decrease) in Accrued Clinical Trial Expenses Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Tranche three Share-Based Payment Arrangement, Tranche Three [Member] Net loss Net loss Net loss Segment net loss Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Tranche two Share-Based Payment Arrangement, Tranche Two [Member] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Interest income Investment Income, Interest Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Research and development service agreements, current Research And Development Service Agreements, Current Research And Development Service Agreements, Current Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]